Oophorectomy followed by postoperative chemotherapy for ovarian metastasis of colorectal cancer: a retrospective analysis

卵巢切除术后化疗治疗结直肠癌卵巢转移:一项回顾性分析

阅读:2

Abstract

BACKGROUND: The incidence of ovarian metastasis from colorectal cancer is low but the prognosis is extremely poor; however, the prognostic factors remain unclear and there are currently no guidelines for the treatment of ovarian metastasis from colorectal cancer. This study evaluated the impact of resection of ovarian metastasis from colorectal cancer and postoperative chemotherapy on patient prognosis. METHODS: This retrospective study analyzed patients with ovarian metastasis from colorectal cancer between January 2009 and December 2019. Factors with P < 0.1 in univariable analysis were considered as potentially prognostic factors and were incorporated into multivariable analysis with Cox proportional hazards regression models. Hazard ratios (HRs) with 95% confidence intervals (CIs) were analyzed. A two-sided P value < 0.05 was considered significant. RESULT: A total of 213 patients with ovarian metastasis from colorectal cancer were included in the study. Univariable analysis identified that the resection of primary tumor, extraovarian metastasis, oophorectomy, postoperative chemotherapy and mismatch repair (MMR) status as potentially prognostic factors. The median survival times in patients with and without oophorectomy were 25 and 11 months, respectively. Chemotherapy after surgery was associated with a longer median overall survival compared with patients without chemotherapy (25 versus 20 months). The median survival time for patients with dMMR status was 36 months, compared to 25 months for those with pMMR status. Multivariable analysis confirmed that oophorectomy (HR = 10.476, 95% CI, 5.536-19.825; P < 0.001), postoperative chemotherapy (HR = 2.232, 95% CI, 1.538-3.238; P < 0.001) and MMR status (HR = 1.967, 95% CI, 1.026-3.772; P = 0.042) were independent prognostic factors for overall survival in patients with ovarian metastasis from colorectal cancer. CONCLUSION: Oophorectomy, postoperative chemotherapy, and dMMR status may offer survival benefits for colorectal cancer patients with ovarian metastasis; however, the main findings from current study warrant further validations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。